Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients

Sirot, 1988, Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid‐mediated beta‐lactamases markedly active against third‐generation cephalosporins: epidemiologic studies, Rev Infect Dis, 10, 850, 10.1093/clinids/10.4.850 Knothe, 1983, Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens, Infection, 11, 315, 10.1007/BF01641355 Arlet, 1991, Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV‐4 β‐lactamase, Eur J Clin Microbiol Infect Dis, 9, 797, 10.1007/BF01967377 Meyer, 1993, Nosocomial outbreak of Klebsiella pneumoniae resistant to late‐generation cephalosporins, Ann Intern Med, 119, 353, 10.7326/0003-4819-119-5-199309010-00001 Peña, 1998, Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended‐spectrum β‐lactamases, Antimicrob Agents Chemother, 42, 53, 10.1128/AAC.42.1.53 Bauernfeind, 1987, Novel R‐factor‐borne β‐lactamase conferring resistance to cephalosporins, Infection, 15, 257, 10.1007/BF01644127 Schiappa, 1996, Ceftazidime‐resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case‐control and molecular epidemiologic investigation, J Infect Dis, 174, 529, 10.1093/infdis/174.3.529 Wiener, 1999, Multiple antibiotic‐resistant Klebsiella and Escherichia coli in nursing homes, JAMA, 281, 517, 10.1001/jama.281.6.517 Lucet, 1996, Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition, Clin Infect Dis, 22, 430, 10.1093/clinids/22.3.430 Paterson, 2001, Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended‐spectrum β‐lactamases: implications for the clinical microbiology laboratory, J Clin Microbiol, 39, 2206, 10.1128/JCM.39.6.2206-2212.2001 Ho, 2002, Bacteremia caused by Escherichia coli producing extended‐spectrum beta‐lactamase: a case‐control study of risk factors and outcomes, Scand J Infect Dis, 34, 567, 10.1080/00365540210147516 Rodriguez‐Baños, 2004, Epidemiology and clinical features of infections caused by extended‐spectrum beta‐lactamase‐producing Escherichia coli in nonhospitalized patients, J Clin Microbiol, 42, 1089, 10.1128/JCM.42.3.1089-1094.2004 Harris, 2001, Methodological principles of case‐control studies that analyzed risk factors for antibiotic resistance: a systematic review, Clin Infect Dis, 32, 1055, 10.1086/319600 Garner, 1988, CDC definitions for nosocomial infections, 1988, Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3 National Committee for Clinical Laboratory Standards, 2004 Legrand, 1989, Detection of extended broad‐spectrum beta‐lactamases in Enterobacteriaceae in four French hospitals, Eur J Clin Microbiol Infect Dis, 8, 527, 10.1007/BF01967473 Coque, 2002, Genes encoding TEM‐4, SHV‐2, and CTX‐M‐10 extended‐spectrum β‐lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989–2000), Antimicrob Agents Chemother, 46, 500, 10.1128/AAC.46.2.500-510.2002 Sabaté, 2002, β‐Lactamases involved in resistance to broad‐spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain), J Antimicrob Chemother, 49, 989, 10.1093/jac/dkf057 Paterson, 2000, Epidemiology of ciprofloxacin resistance and its relationship to extended‐spectrum β‐lactamase production in Klebsiella pneumoniae isolates causing bacteremia, Clin Infect Dis, 30, 473, 10.1086/313719 Lautenbach, 2001, Epidemiological investigation of fluoroquinolone resistance in infections due to extended‐spectrum β‐lactamase‐producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis, 33, 1288, 10.1086/322667 Shuttleworth, 2004, The rising incidence of antibiotic‐resistant ESBL producing E. coli, Nurs Times, 100, 30 Vollaard, 1994, Colonization resistance, Antimicrob Agents Chemother, 38, 409, 10.1128/AAC.38.3.409